These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 15497198)

  • 1. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.
    Manca A; Hawkins N; Sculpher MJ
    Health Econ; 2005 May; 14(5):487-96. PubMed ID: 15497198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models.
    Manca A; Rice N; Sculpher MJ; Briggs AH
    Health Econ; 2005 May; 14(5):471-85. PubMed ID: 15386662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
    Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial.
    Sculpher M; Manca A; Abbott J; Fountain J; Mason S; Garry R
    BMJ; 2004 Jan; 328(7432):134. PubMed ID: 14711748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
    McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
    Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.
    Briggs AH; Lozano-Ortega G; Spencer S; Bale G; Spencer MD; Burge PS
    Value Health; 2006; 9(4):227-35. PubMed ID: 16903992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economic analysis of a cluster-randomised trial (OptiBIRTH) designed to increase rates of vaginal birth after caesarean section.
    Fobelets M; Beeckman K; Healy P; Grylka-Baeschlin S; Nicoletti J; Devane D; Gross MM; Morano S; Daly D; Begley C; Putman K
    BJOG; 2019 Jul; 126(8):1043-1051. PubMed ID: 30957402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy.
    Garry R; Fountain J; Brown J; Manca A; Mason S; Sculpher M; Napp V; Bridgman S; Gray J; Lilford R
    Health Technol Assess; 2004 Jun; 8(26):1-154. PubMed ID: 15215018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation.
    Sharples L; Everett C; Singh J; Mills C; Spyt T; Abu-Omar Y; Fynn S; Thorpe B; Stoneman V; Goddard H; Fox-Rushby J; Nashef S
    Health Technol Assess; 2018 Apr; 22(19):1-132. PubMed ID: 29701167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).
    Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S
    BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
    Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
    Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation.
    Murray A; Lourenco T; de Verteuil R; Hernandez R; Fraser C; McKinley A; Krukowski Z; Vale L; Grant A
    Health Technol Assess; 2006 Nov; 10(45):1-141, iii-iv. PubMed ID: 17083853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
    Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
    J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-Effectiveness Analysis of Morcellation Hysterectomy for Myomas.
    Bortoletto P; Einerson BD; Miller ES; Milad MP
    J Minim Invasive Gynecol; 2015; 22(5):820-6. PubMed ID: 25827327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.
    Spencer M; Briggs AH; Grossman RF; Rance L
    Pharmacoeconomics; 2005; 23(6):619-37. PubMed ID: 15960557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.
    Hoogendoorn M; Feenstra TL; Asukai Y; Briggs AH; Hansen RN; Leidl R; Risebrough N; Samyshkin Y; Wacker M; Rutten-van Mölken MP
    Value Health; 2017 Mar; 20(3):397-403. PubMed ID: 28292484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.